Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A After Pars Plana Vitrectomy in Dry Eye Disease
ChiCTR2600129992Phase 4Completed
- Sponsor
- The 2nd Affiliated Hospital of Harbin Medical University
- Start
- Aug 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of cyclosporine in dry eye syndrome (DED) (2 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: Schirmer test (tear secretion) and Ocular Surface Disease Index (OSDI) score. Started Aug 2026; status: completed.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2600129992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600129992.